This report provides a comprehensive analysis of the global HPV vaccine for men market, projecting steady growth through 2032. It examines the industry's role in preventing genital warts and various cancers, such as penile and anal cancer, while evaluating market dynamics across key regions including the Americas, APAC, and Europe. By segmenting the market by type and application, the study highlights competitive strategies of major players like Merck and Wantai Biotech to identify emerging opportunities.

Market Overview

Global Market Projections

The global HPV Vaccine for Men (Male HPV Vaccine) market size is predicted to grow from US$ 22.9 million in 2025 to US$ 37.31 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Product Definition and Clinical Significance

Male HPV vaccine refers to the HPV vaccine developed specifically for men. HPV (human papillomavirus) is a virus that can infect the skin and mucous membranes, and is divided into low-risk and high-risk types:

• Low-risk HPV infection: May cause skin lesions such as genital warts.
• High-risk HPV infection: Associated with an increased risk of malignant tumors such as penile cancer, anal cancer, and oral cancer.

Therefore, HPV vaccination for men is of great significance in preventing these diseases, which can not only prevent related diseases but also reduce the risk of transmission.

Regional Market Outlooks

• United States: The market for HPV Vaccine for Men is projected to experience growth from 2025 through 2032.
• China: The market for HPV Vaccine for Men is projected to experience growth from 2025 through 2032.
• Europe: The market for HPV Vaccine for Men is projected to experience growth from 2025 through 2032.

Report Scope and Methodology

Research Objectives

LP Information, Inc. (LPI)'s newest research report, the “HPV Vaccine for Men (Male HPV Vaccine) Industry Forecast,” looks at past sales and reviews total world HPV Vaccine for Men (Male HPV Vaccine) sales in 2025, providing a comprehensive analysis by region and market sector of projected HPV Vaccine for Men (Male HPV Vaccine) sales for 2026 through 2032. With HPV Vaccine for Men (Male HPV Vaccine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HPV Vaccine for Men (Male HPV Vaccine) industry.

This Insight Report provides a comprehensive analysis of the global HPV Vaccine for Men (Male HPV Vaccine) landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies with a focus on HPV Vaccine for Men (Male HPV Vaccine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HPV Vaccine for Men (Male HPV Vaccine) market.

Analytical Approach

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HPV Vaccine for Men (Male HPV Vaccine) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HPV Vaccine for Men (Male HPV Vaccine).

The report presents a comprehensive overview, market shares, and growth opportunities of the HPV Vaccine for Men (Male HPV Vaccine) market by product type, application, key manufacturers, and key regions and countries.

Market Segmentation

Segmentation by Type

• Domestic
• Imported

Segmentation by Application

• Genital Warts
• Penile Cancer and Precancerous Lesions
• Perineal Cancer and Precancerous Lesions
• Perianal Cancer and Precancerous Lesions
• Others

Segmentation by Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on inputs gathered from primary experts and analysis of the company's coverage, product portfolio, and market penetration:

• Merck
• Wantai Biotech
• Kangle Guardian
• Bovaxbio

Market Concentration

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Key Questions Addressed

• What is the 10-year outlook for the global HPV Vaccine for Men (Male HPV Vaccine) market?
• What factors are driving HPV Vaccine for Men (Male HPV Vaccine) market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do HPV Vaccine for Men (Male HPV Vaccine) market opportunities vary by end market size?
• How does HPV Vaccine for Men (Male HPV Vaccine) break out by Type, by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for HPV Vaccine for Men(Male HPV Vaccine) by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for HPV Vaccine for Men(Male HPV Vaccine) by Country/Region, 2021, 2025 & 2032

  • 2.2 HPV Vaccine for Men(Male HPV Vaccine) Segment by Type

    • 2.2.1 Domestic

    • 2.2.2 Imported

    • 2.2.3 HPV Vaccine for Men(Male HPV Vaccine) Sales by Type

      • 2.2.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sale Price by Type (2021-2026)

  • 2.3 HPV Vaccine for Men(Male HPV Vaccine) Segment by Application

    • 2.3.1 Genital Warts

    • 2.3.2 Penile Cancer and Precancerous Lesions

    • 2.3.3 Perineal Cancer and Precancerous Lesions

    • 2.3.4 Perianal Cancer and Precancerous Lesions

    • 2.3.5 Others

    • 2.3.6 HPV Vaccine for Men(Male HPV Vaccine) Sales by Application

      • 2.3.6.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sale Market Share by Application (2021-2026)
      • 2.3.6.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue and Market Share by Application (2021-2026)
      • 2.3.6.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Breakdown Data by Company

    • 3.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Sales by Company (2021-2026)

    • 3.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Company (2021-2026)

  • 3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Revenue by Company (2021-2026)

    • 3.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Company (2021-2026)

    • 3.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Company (2021-2026)

  • 3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sale Price by Company

  • 3.4 Key Manufacturers HPV Vaccine for Men(Male HPV Vaccine) Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers HPV Vaccine for Men(Male HPV Vaccine) Product Location Distribution

    • 3.4.2 Players HPV Vaccine for Men(Male HPV Vaccine) Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for HPV Vaccine for Men(Male HPV Vaccine) by Geographic Region

  • 4.1 World Historic HPV Vaccine for Men(Male HPV Vaccine) Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country/Region (2021-2026)

    • 4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas HPV Vaccine for Men(Male HPV Vaccine) Sales Growth

  • 4.4 APAC HPV Vaccine for Men(Male HPV Vaccine) Sales Growth

  • 4.5 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Growth

  • 4.6 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Growth

• 5 Americas

  • 5.1 Americas HPV Vaccine for Men(Male HPV Vaccine) Sales by Country

    • 5.1.1 Americas HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026)

    • 5.1.2 Americas HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021-2026)

  • 5.2 Americas HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2026)

  • 5.3 Americas HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC HPV Vaccine for Men(Male HPV Vaccine) Sales by Region

    • 6.1.1 APAC HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021-2026)

    • 6.1.2 APAC HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2021-2026)

  • 6.2 APAC HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2026)

  • 6.3 APAC HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe HPV Vaccine for Men(Male HPV Vaccine) by Country

    • 7.1.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026)

    • 7.1.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021-2026)

  • 7.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2026)

  • 7.3 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) by Country

    • 8.1.1 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021-2026)

  • 8.3 Middle East & Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of HPV Vaccine for Men(Male HPV Vaccine)

  • 10.3 Manufacturing Process Analysis of HPV Vaccine for Men(Male HPV Vaccine)

  • 10.4 Industry Chain Structure of HPV Vaccine for Men(Male HPV Vaccine)

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors

  • 11.3 HPV Vaccine for Men(Male HPV Vaccine) Customer

• 12 World Forecast Review for HPV Vaccine for Men(Male HPV Vaccine) by Geographic Region

  • 12.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size Forecast by Region

    • 12.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Forecast by Region (2027-2032)

    • 12.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global HPV Vaccine for Men(Male HPV Vaccine) Forecast by Type (2027-2032)

  • 12.7 Global HPV Vaccine for Men(Male HPV Vaccine) Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Merck

    • 13.1.1 Merck Company Information

    • 13.1.2 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolios and Specifications

    • 13.1.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Merck Main Business Overview

    • 13.1.5 Merck Latest Developments

  • 13.2 Wantai Biotech

    • 13.2.1 Wantai Biotech Company Information

    • 13.2.2 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolios and Specifications

    • 13.2.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Wantai Biotech Main Business Overview

    • 13.2.5 Wantai Biotech Latest Developments

  • 13.3 Kangle Guardian

    • 13.3.1 Kangle Guardian Company Information

    • 13.3.2 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolios and Specifications

    • 13.3.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Kangle Guardian Main Business Overview

    • 13.3.5 Kangle Guardian Latest Developments

  • 13.4 Bovaxbio

    • 13.4.1 Bovaxbio Company Information

    • 13.4.2 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolios and Specifications

    • 13.4.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Bovaxbio Main Business Overview

    • 13.4.5 Bovaxbio Latest Developments

• 14 Research Findings and Conclusion